Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6168457 | Urology | 2011 | 7 Pages |
Abstract
National data support evidence that RP can result in encouraging midterm oncologic outcomes for the management of high-risk PCa. At 5 years after surgery, 75% of patients remain disease free. Our easy-to-use risk stratification might help clinicians to better predict the clinical and PSA outcomes of high-risk patients after surgery.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Guillaume Ploussard, Alexandra Masson-Lecomte, Jean-Baptiste Beauval, Adil Ouzzane, Romain Bonniol, François Buge, Saad Fadli, Morgan Rouprêt, Xavier Rebillard, Nicolas Gaschignard, Christian Pfister, Arnauld Villers, Michel Soulié, Laurent Salomon,